Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 855-864

  Wanless, Ian R ^a,c   Belgiorno, Jocelyne ^b   Huet, Pierre Michel ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; COLLAGEN; DIETHYLSTILBESTROL; DIPYRIDAMOLE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL INTAKE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROGENESIS; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STELLATE CELL;

EID: 0029829651     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855188     Document Type: Article

References (64)

1. Bullock BC, Paula R, Rudel LL. Dietary-induced cirrhosis in the pig-tailed macaque (Macaca nemestrina). Fed Proc 1974;33:626.
2. Lee SS, Ho KJ. Cholesterol fatty liver. Morphological changes in the course of its development in rabbits. Arch Pathol 1975;99:301-306.
3. Gupta PP, Tandon HD, Ramalingaswami V. Cirrhosis of the liver in rabbits induced by a high cholesterol diet - an experimental model. Indian J Med Res 1976;64:1516-1526.
4. Ronnemaa T. Effect of high cholesterol, olive oil diet on the lipids and connective tissue in rat liver. A biochemical study. Scand J Gastroenterol 1976;11:849-855.
5. Temmerman AM, Vonk RJ, Niezen-Koning K, Berger R, Fernandes J. Long-term and short-term effects of dietary cholesterol and fats in the Mongolian gerbil. Ann Nutr Metab 1988;32:177-185.
6. Constantinides P, Gutmann-Auersperg N. Inhibition of progress of preestablished atherosclerosis by diethylstilbestrol in the rabbit. Arch Pathol 1960;70:35-42.
7. Numano F, Katsu K, Kitta T, Shimamoto T. Banti-like syndrome induced by estrogen and cholesterol. Acta Hepatosplenol 1969;16:77-85.
8. Skjaerlund JM. Estrogen protection against atherosclerosis and synthetic estrogen production of cirrhosis in the rabbit. Res Commun Chem Pathol Pharmacol 1992;75:193-208.
9. Joist JH, Dolezel G, Kinlough-Rathbone R, Mustard JF. Effect of diet-induced hyperlipidemia on in vitro function of rabbit platelets. Thromb Res 1976;9:435-445.
10. Peters JR, Elliott JM, Grahame-Smith DG. Effect of oral contraceptives on platelet noradrenaline and 5-hydroxytryptamine receptors and aggregation. Lancet 1979;2:933-936.
11. Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane B2 by platelets in vitro, N Engl J Med 1980;302:6-10.
12. Anonymous The coronary drug project: initial findings leading to modifications of its research protocol. JAMA 1970;214:1303-1313.
13. Suehiro A, Kakishita E, Nagai K. The role of platelet hyperfunction in thrombus formation in hyperlipidemia. Thromb Res 1982;25:331-339.
14. Bremme K, Wramsby H, Andersson O, Wallin M, Blomback M. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 1994;5:205-210.
15. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989;84:1786-1793.
16. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 328:1828-1835.
17. Peterson TC, Isbrucker RA, Hooper ML. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 1994;28:259-270.
18. Wybenga DR, Pileggi VJ, Dirstine PH, DiGiorgio J. Direct manual determination of serum total cholesterol with a single stable reagent. Clin Chem 1970;16:980-984.
19. Schwarz HP, Bergman K, Paumgartner G. A simple method for the estimation of bile acids in serum. Clin Chim Acta 1974;50:197-206.
20. Rojkind M, Gonzales E. An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins. Anal Biochem 1974;57:1-7.
21. Gascon-Barre M, Huet PM, Belgiorno J. Estimation of collagen content of liver specimens. Variation between animals and between hepatic lobes in cirrhotic rats. J Histochem Cytochem 1989;37:377-381.
22. Lopez-DeLeon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985;3:737-743.
23. Mastaï R, Laganière S, Wanless IR, Giroux L, Rocheleau B, Huet P-M. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. 2. hemodynamic and drug disposition studies. HEPATOLOGY 1996; 24:865-870.
24. Wilson JD. The quantification of cholesterol excretion and degradation in the isotopic steady state in the rat: the influence of dietary cholesterol. J Lipid Res 1964;5:409-417 .
25. Hellstrom K. On the bile and neutral fecal steroid excretion in man and rabbits following cholesterol feeding. Acta Physiol Scand 1965;63:21-35.
26. Quintao E, Grundy SM, Ahrens EHJ. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res 1971;12:233-247.
27. Forker EL. The effect of estrogen on bile formation in the rat. J Clin Invest 1969;48:654-663.
28. Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. HEPATOLOGY 1983;3:489-496.
29. Tuchweber B, Perea A, Carrillo MC, Villalon L, Lemay J, Yousef IM. Low protein diet protects against ethinyl estradiol-induced cholestasis. Nutr Res 1994;14:707-716.
30. Schaffner F, Popper H. Capillarization of the hepatic sinusoids in man. Gastroenterology 1963;4:239-242.
31. Nanji AA, French SW. Relationship between pork consumption and cirrhosis. Lancet 1985;1:681-683.
32. Patek AJ, Bowry S, Hayes KC. Cirrhosis of choline deficiency in the Rhesus monkey. Possible role of cholesterol. Proc Soc Exp Biol Med 1975;148:370-374.
33. Hunt CE, Diani AR, Brown PK, Kaluzny MA, Epps DE. Diet induced atherogenic hyperlipoproteinaemia and liver injury in cynomolgus macaques. Br J Exp Pathol 1986;67:235-249.
34. Phillips MJ, Poucell S, Patterson J, Valencia P. The liver: an atlas and text of ultrastructural pathology. New York, NY: Raven, 1987.
35. Davis RA, Kern F, Showalter R, Sutherland E, Sinensky M, Simon FR. Alterations of hepatic Na,K-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci USA 1978;75:4130-4134.
36. Sweeney GD, Cole FM. Effects of ethynyl estradiol on liver microsomal mixed function oxygenase activity in male rats. Lab Invest 1980;42:231-235.
37. Liehr JG, DaGue BB, Ballatore AM, Henkin J. Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. Biochem Pharmacol 1983;32:3711-3718.
38. Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor driven proliferation of fibroblasts. HEPATOLOGY 1993;17:486-493.
39. Gressner AM, Bachem MG. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases - liver fibrosis as a paradigm. Ann Biol Clin (Paris) 1994;52:205-226.
40. Marra F, Choudhury GG, Pinzani M, Abboud HE. Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology 1994;107:1110-1117.
41. Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Detection of enhanced in vivo platelet alpha-granule release in different patient groups. Comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays. Thromb Haemost 1984;52:183-187.
42. Hughes RD, Lane DA, Ireland H, Langley PG, Gimson AE, Williams R. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clin Sci 1985;68:701-707.
43. Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease: a study of 200 cases. Gastroenterology 1982;83:786-796.
44. Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986;39:63-67.
45. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. HEPATOLOGY 1995;21: 1238-1247.
46. Kelleher CC. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease. Am J Obstet Gynecol 1990;163:392-395.
47. Florentin RA, Nam SC, Lee KT, Thomas WA. Increased 3H-thymidine incorporation into endothelial cells of swine fed cholesterol for 3 days. Exp Mol Pathol 1969;10:250-255.
48. Armstrong ML, Peterson RE, Hoak JC, Megan MB, Cheng FH, Clarke WR. Arterial platelet accumulation in experimental hypercholesterolemia. Atherosclerosis 1980;36:89-100.
49. Wanless IR. The effect of dietary cholesterol on platelet survival in the rabbit. A study using 14C-serotonin and 51-Chromium double labelled platelets. Thromb Haemost 1984;52:85-89.
50. Renaud S, Lecompte F. Hypercoagulability induced by hyperlipidemia in rat, rabbit and man. Role of platelet factor 3. Circ Res 1970;27:1003-1011.
51. Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983;50:852-856.
52. Fahr A, Langer R, Sziegoliet W, Beitz J, Krause P, Forster W. In vivo synthesis of prostacyclin-like substances in human varicose veins. Biomed Biochem Acta 1984;43:K6-K8.
53. Dembinska-Kiec A, Rucker W, Schonhofer PS. Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation. Atherosclerosis 1979;33:315-327.
54. Lautt WW. Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc 1983;42:1662-1666.
55. Kuwano H, Yano K, Ohno S, Ikebe M, Kitamura K, Toh Y, Mori M, et al. Dipyridamole inhibits early wound healing in rat skin incisions. J Surg Res 1994;56:267-270.
56. Iuliano L, Pratico D, Ghiselli A, Bonavita MS, Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids 1992;27:349-353.
57. Jablonska-Kaszewska I, Dabrowska E, Boj E, Baranowska B, Vogel M. Effect of dipyridamole on liver changes during acute poisoning with carbon tetrachloride in rats. Pol Arch Med Wewn 1979;62:511-517.
58. Kast A, Nishikawa J, Yabe T. Decrease of carbon tetrachloride liver toxicity in rats given dipyridamole. Exp Pathol 1982;21:123-133.
59. Perezalvarez V, Bobadillalugo RA, Muriel P, Favari L, Villanuevalopez C. Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacology 1993;7:330-336.
60. Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Dipyridamole and platelet release of platelet-derived growth factor. Platelets 1994;5:105-108.
61. Breddin HK. Current perspectives in the antiplatelet therapy of thrombotic disorders. Semin Thromb Hemost 1989;15:144-149.
62. Suren A, Bauer FE, Rosenkranz B, Bircher J. Effect of pentoxifylline on liver plasma flow in normal man. Eur J Clin Pharmacol 1991;41:233-237.
63. Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil Superoxide anion production. Infect Immun 1992;60:4504-4509.
64. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992;10:197-214.